Insider Shareholders with Direct Ownership of Mirum Pharmaceuticals, Inc. (MIRM)
This section provides a comprehensive overview of the insiders with direct ownership of Mirum Pharmaceuticals, Inc. (MIRM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Mirum Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
2,445,147 | 0 | 2,445,147 $95.4 Million | 1 |
Jul 22, 2019
Added 19.04%
|
|
New Enterprise Associates 16, L.P.
> 10% Shareholder |
0 | 2,000,000 | 2,186,243 $85.3 Million | 1 |
Jun 13, 2023
Reduced 47.78%
|
|
Christopher Peetz
CHIEF EXECUTIVE OFFICER |
159,334 | 25,551 | 126,783 $4.94 Million | 16 |
Jul 23, 2024
Added 21.15%
|
|
Lara Longpre
CHIEF DEVELOPMENT OFFICER |
34,203 | 4,834 | 104,407 $4.07 Million | 16 |
Feb 02, 2024
Reduced 0.8%
|
|
Edwin Jonathan Tucker
Chief Medical Officer |
41,202 | 1,364 | 45,838 $1.79 Million | 8 |
Nov 10, 2021
Added 0.15%
|
|
Eric Bjerkholt
CHIEF FINANCIAL OFFICER |
32,804 | 0 | 32,804 $1.28 Million | 5 |
Sep 11, 2024
Added 35.85%
|
|
Ian Clements
Chief Financial Officer |
27,555 | 1,574 | 30,011 $1.17 Million | 11 |
Nov 10, 2022
Added 1.07%
|
|
Peter Radovich
PRESIDENT AND COO |
38,037 | 11,669 | 29,013 $1.13 Million | 16 |
Mar 25, 2024
Reduced 12.92%
|
|
Pamela Vig
CHIEF SCIENTIFIC OFFICER |
63,143 | 37,349 | 27,406 $1.07 Million | 18 |
Jun 24, 2024
Reduced 52.72%
|
|
Jolanda Howe
SVP, GLOBAL CONTROLLER |
9,169 | 8,512 | 2,426 $94,614 | 12 |
Jul 02, 2024
Reduced 13.39%
|
|
Carmen Chang
> 10% Shareholder |
135 | 0 | 135 $5,265 | 1 |
Jun 13, 2023
Added 50.0%
|
|
Anthony A. Florence Jr.
> 10% Shareholder |
384 | 0 | 0 $0 | 1 |
N/A
|
| 43,824 | 43,824 | 0 $0 | 8 |
Sep 14, 2023
Reduced 100.0%
|
|
| 5,000 | 5,000 | 0 $0 | 2 |
Jun 05, 2024
Reduced 100.0%
|
|
|
Nea Partners 16, L.P.
> 10% Shareholder |
30,000 | 30,000 | 0 $0 | 2 |
Jun 13, 2023
Reduced 100.0%
|